Novacyt - Asset Resilience Ratio

Latest as of June 2025: 37.69%

Novacyt (ALNOV) has an Asset Resilience Ratio of 37.69% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Novacyt total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€23.72 Million
≈ $27.73 Million USD Cash + Short-term Investments

Total Assets

€62.92 Million
≈ $73.56 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Novacyt's Asset Resilience Ratio has changed over time. See ALNOV net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Novacyt's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Novacyt.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €23.71 Million 37.68%
Short-term Investments €10.00K 0.02%
Total Liquid Assets €23.72 Million 37.69%

Asset Resilience Insights

  • Very High Liquidity: Novacyt maintains exceptional liquid asset reserves at 37.69% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Novacyt Industry Peers by Asset Resilience Ratio

Compare Novacyt's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Beijing Wandong Medical Technology Co Ltd
SHG:600055
Medical Devices 4.92%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
MODULIGHT OY EO 1
F:78W
Medical Devices 22.31%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.39%
Theradiag SA
PA:ALTHE
Medical Devices 15.59%
Nova EYE Medical Ltd
AU:EYE
Medical Devices 11.08%

Annual Asset Resilience Ratio for Novacyt (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Novacyt.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 43.13% €30.46 Million
≈ $35.61 Million
€70.63 Million
≈ $82.58 Million
+43.12pp
2023-12-31 0.01% €9.00K
≈ $10.52K
€133.81 Million
≈ $156.44 Million
-61.73pp
2022-12-31 61.73% €86.98 Million
≈ $101.69 Million
€140.90 Million
≈ $164.73 Million
+6.34pp
2021-12-31 55.39% €101.75 Million
≈ $118.96 Million
€183.70 Million
≈ $214.76 Million
+16.22pp
2020-12-31 39.17% €91.77 Million
≈ $107.29 Million
€234.28 Million
≈ $273.89 Million
+33.33pp
2019-12-31 5.84% €1.55 Million
≈ $1.81 Million
€26.54 Million
≈ $31.03 Million
+2.33pp
2018-12-31 3.51% €1.03 Million
≈ $1.20 Million
€29.31 Million
≈ $34.27 Million
+3.48pp
2017-12-31 0.03% €8.88K
≈ $10.38K
€30.20 Million
≈ $35.31 Million
0.00pp
2016-12-31 0.03% €8.52K
≈ $9.97K
€25.95 Million
≈ $30.34 Million
-6.77pp
2015-12-31 6.80% €858.99K
≈ $1.00 Million
€12.62 Million
≈ $14.76 Million
+6.77pp
2014-12-31 0.04% €7.81K
≈ $9.13K
€20.77 Million
≈ $24.28 Million
-31.41pp
2013-12-31 31.45% €837.46K
≈ $979.08K
€2.66 Million
≈ $3.11 Million
-10.05pp
2012-12-31 41.50% €1.37 Million
≈ $1.60 Million
€3.30 Million
≈ $3.86 Million
+38.74pp
2011-12-31 2.76% €34.80K
≈ $40.69K
€1.26 Million
≈ $1.47 Million
+2.24pp
2010-12-31 0.53% €10.00K
≈ $11.69K
€1.90 Million
≈ $2.22 Million
+0.00pp
2009-12-31 0.52% €10.00K
≈ $11.69K
€1.92 Million
≈ $2.24 Million
-14.29pp
2008-12-31 14.81% €244.00K
≈ $285.26K
€1.65 Million
≈ $1.93 Million
--
pp = percentage points

About Novacyt

PA:ALNOV France Medical Devices
Market Cap
$26.46 Million
€22.64 Million EUR
Market Cap Rank
#24136 Global
#394 in France
Share Price
€0.32
Change (1 day)
-13.38%
52-Week Range
€0.32 - €0.72
All Time High
€13.24
About

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive h… Read more